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1. Introduction
Studies on the association between somatic chronic diseases in adolescents with intellectual disability (ID-adolescents)
and the full range of pervasive developmental disorder behavior (PDD behavior), in particular milder forms of PDD behavior
(mild PDD behavior), are hardly available. Mild PDD behavior is a term reserved for those who do not meet the criteria for
severe PDD behavior like in autism or Asperger syndrome.Mild PDD behavior is widespread among ID-adolescents and has a
profound effect on their daily functioning (de Bildt et al., 2005a; de Bildt, Sytema, Kraijer, & Minderaa, 2005; Hartman,
Luteijn, Serra, & Minderaa, 2006; Kraijer, 2000).
Literature shows a positive association between severity of ID and mild PDD behavior in adolescents (de Bildt et al.,
2005a). This positive association is caused by the fact that ID-adolescents, especially those with lower levels of ID, have a
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Attention deﬁcit hyperactivity disorder
A B S T R A C T
Evidence on the association between somatic chronic diseases in ID-adolescents and the
full range of pervasive developmental disorder behavior (PDD behavior) is scarce. The aim
of the present study is to assess the association between somatic chronic diseases in ID-
adolescents and mild PDD behavior. We obtained data on 1044 ID-adolescents, aged 12–
18, attending secondary schools in the Netherlands. Parents of the adolescents completed
the Dutch version of the Children’s Social Behavior Questionnaire (CSBQ) parent version,
covering a wide range of PDD behavior, and questions about chronic diseases and
background characteristics of their child. ID-adolescents with somatic chronic diseases
showed more PDD behavior, in particular milder forms, than their peers without chronic
diseases. In addition, ID-adolescents with somatic chronic diseases in combination with
pervasive development disorders (PDD) and attention deﬁcit hyperactivity disorder
(ADHD) also showedmore PDD behavior than their peers with only PDD/ADHD. Clinicians
should be extra alert on PDD behavior, in particular the milder forms, in ID-adolescents
when somatic chronic diseases are present. However, to strengthen our results about the
relationship between somatic chronic diseases in ID-adolescents and PDD behavior
studies are needed using both the CSBQ and standardized diagnostic instruments.
 2009 Elsevier Ltd. All rights reserved.
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greater chance on both pervasive development disorders (PDD) (de Bildt et al., 2005a; Harris et al., 2008; Matson &
Shoemaker, 2009;Walker et al., 2004) and attention deﬁcit hyperactivity disorder (ADHD) (Emerson&Hatton, 2007;Matson
& Shoemaker, 2009). Although ADHD and PDD have different nosological diagnoses, both diagnostic categories partly
include similar symptoms like deﬁcits in social interaction, impulsivity, attention and hyperactivity deﬁcit (Gallagher,
Bellgrove, Hawi, Segurado, & Fitzgerald, 2007). These deﬁcits are also associated with mild PDD behavior (de Bildt et al.,
2005a; Hartman et al., 2006; Nijmeijer et al., 2009).
Literature also suggests that adolescents with somatic chronic diseases showmore PDD behavior than adolescents in the
general population (Ekstro¨m, Hakenas-Plate, Samuelsson, Tulinius, & Wentz, 2008; Fombonne, 2009; Freeman, Roberts, &
Daneman, 2005; Hendriksen & Vles, 2008; Kilincaslan & Mukaddes, 2009; Nordin & Gillberg, 1996; Steffenburg, Gillberg, &
Steffenburg, 1996; Thome-Souza et al., 2004), but only two studies have focused explicitly on ID-adolescents with somatic
chronic diseases (Nordin & Gillberg, 1996; Steffenburg et al., 1996). None of the aforementioned studies used instruments
that were suitable for screening or diagnosing mild PDD behavior (Hartman et al., 2006).
Studies on the association between somatic chronic diseases in ID-adolescents and PDD behavior, in particular milder
forms of PDD behavior, are highly needed. Professionals do not always recognize mild PDD behavior in (ID-)adolescents (de
Bildt et al., 2005b; Kilincaslan & Mukaddes, 2009). Evidence on an association between somatic chronic diseases in ID-
adolescents and mild PDD behavior may thus increase the attentiveness of professionals for mild PDD behavior, enabling
earlier diagnosis and treatment. PDD behavior is very disabling in social and interpersonal situations and hinder successful
participation in society (de Bildt et al., 2005a; Haccou & Hamond, 2006; Matson, Wilkins, Smith, & Ancona, 2008).
The aim of this study is to assess the association between somatic chronic diseases in ID-adolescents and PDD behavior, in
particular the milder forms of PDD behavior.
2. Methods
2.1. Participants and procedure
We collected data on adolescents with a borderline, mild, moderate or severe ID aged 12–18 years in two provinces in the
north of the Netherlands: Groningen and Drenthe (total population about 1.1 million people).
Nearly all adolescents of the target population attended secondary schools (schools for practical training) or special
secondary schools (regional expertise centers). ID-adolescents attending schools for practical training can be classiﬁed as
mainly educable and have IQs between 60 and 80. ID-adolescents attending regional expertise centers can be classiﬁed as
mainly trainable and have IQs between 30 and 60 (Dekker, Koot, Van der Ende, & Verhulst, 2002). ID-adolescents not
attending secondary schools, most of them with profound ID, were not included.
In the current school-based cross-sectional research project, 88% of the schools for practical training and regional
expertise centers in both provinces participated. Non-participating schools did not differ from participating schools
regarding urbanization of the catchment area and number of students. All parents of the 2156 adolescents aged 12–18 years
received a questionnaire and a reminder when they did not respond. One thousand forty four parents returned the
questionnaire (48.4%). Adolescents in the response and non-response group did not differ regarding age (t-test = 1.751, ns),
but the response group had a higher proportion of girls (x2 = 5.9; p< 0.05) and a higher proportion of adolescents with
borderline or mild ID (x2 = 9.8; p< 0.05). However, the effect sizes for both variables were negligible; Cohen’sW were 0.06
and 0.07, respectively (Cohen, 1988).




The target population had been ofﬁcially classiﬁed as having ID by an independent committee established by the Dutch
Ministry of Education, Culture and Science (Dutch Eurydice Unit, 2007). The classiﬁcation of ID is based on a set of objective
criteria, with theDutch version of theWechsler Intelligence Scale for Children-3rd Edition (Kort et al., 2002;Wechsler, 1991),
and the Snijders-Oomen Nonverbal Intelligence Test-Revised (Snijders et al., 2003) as core ones.
2.2.2. Chronic diseases
Chronic diseases in ID-adolescents were measured by the National Permanent Survey on Living Conditions
questionnaire (POLS); module health and labor, part chronic diseases in children (Statistics Netherlands, 2003). POLS part
chronic diseases in children covers the most prevalent chronic diseases such as: ear, eye, skin diseases, diseases of the
nervous, musculoskeletal, blood and circulatory, respiratory, digestive, and endocrine, nutritional and metabolic systems
and ADHD. Questions were added about the presence of pervasive developmental disorders. Parents were asked to ﬁll in
the presence or absence of each speciﬁc chronic disease in the last 12 months for their child. Parents were also offered the
possibility to mention the presence of chronic diseases that were not listed in the questionnaire. POLS was developed by
Statistics Netherlands and is yearly used in a representative sample (n 10.000) of the Dutch population (Otten &
Winkels, 1998).
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2.2.3. Pervasive development disorder behavior
PDD behavior was measured by the Dutch version of the Children’s Social Behavior Questionnaire (CSBQ) parent version.
The CSBQ has 49 items describing a broad range of behavioral features, including milder forms that are typical of PDD. The
items can be allocated to six subscales: ‘‘not optimally tuned to the social situation’’ (not tuned behavior; 11 items
addressing emotional overreacting and stubbornness/disobedience), ‘‘reduced contact and social interest’’ (social
withdrawn; 12 items), ‘‘orientation problems in time, place, or activity’’ (orientation problems; 8 items), ‘‘difﬁculties in
understanding of social information’’ (not understanding; 7 items), ‘‘stereotyped behavior’’ (stereotyped behavior; 8 items),
and ‘‘fear of and resistance to changes’’ (fear of changes; 3 items). Each item can be marked as ‘‘does not apply’’ to the child
(score 0), ‘‘sometimes or somewhat applies’’ (score 1), or ‘‘clearly or often applies’’ (score 2) (de Bildt et al., 2005a; Hartman,
Luteijn, Moorlag, de Bildt, & Minderaa, 2007; Hartman et al., 2006). Subscale scores can be computed by summing scores on
the items; range 0–6 (fear of changes) to 0–24 (social withdrawn). Lower scores on the subscales reﬂect milder forms of PDD
behavior, whereas higher scores reﬂect more severe forms of PDD behavior. A total score can also be calculated by summing
the scores of the subscales (range 0–98). Although the CSBQ was originally developed for and investigated in children with
normal intelligence, the psychometric qualities of the CSBQ in children with ID were found to be good (de Bildt et al., 2009;
Luteijn, Luteijn, Jackson, Volkmar, & Minderaa, 2000).
2.2.4. Background characteristics
The questionnaire comprised questions on age, gender and school type of the adolescent.
2.3. Analysis
The CSBQ item scores were transformed to summative scores on the six subscales and a total CSBQ score, respectively.
Subsequently, adolescents were categorized in a group without chronic diseases, with only somatic chronic diseases, with
only PDD/ADHD, and with somatic chronic diseases in combination with PDD/ADHD. Adolescents with other psychiatric
disorders (n = 102) were excluded from the analyses.
We tested via Univariate Analysis of Variance with Bonferroni post-hoc correction the mean differences between the
group with somatic chronic diseases versus without chronic diseases and the mean differences between the group with
somatic chronic diseases in combinationwith PDD/ADHDversus the groupwith PDD/ADHD. Both analyseswere adjusted for
level of ID (as measured by school type). For all mean differences, effect sizes (Cohen’s D) were calculated (Cohen, 1988).
3. Results
Table 1 shows the background characteristics of the adolescents. The gender ratio, 58.2% boys and 41.8% girls, was similar
to the ratio boys and girls with ID in the Netherlands (van Schrojenstein Lantman-de Valk et al., 2002).
Tables 2 and 3 shows themean scores and standard deviations of the four subgroups of ID-adolescents on all CSBQ scales.
Table 2 shows that, adjusted for level of ID, ID-adolescents with somatic chronic diseases had statistically signiﬁcant
highermean scores on all CSBQ scales compared to ID-adolescentswithout chronic diseases. According to Cohen’s criteria, all
the effect sizes were small, except for those associated with the Orientation problem scale; medium effect size.
In addition, Table 3 shows that, adjusted for level of ID, ID-adolescents with comorbidity of somatic chronic diseases in
combination with PDD/ADHD had statistically signiﬁcant higher mean scores on ﬁve of the six CSBQ subscales and total
CSBQ score compared to ID-adolescents with only PDD/ADHD. The effect sizes were small for all of the signiﬁcant
associations.
As shown in both Tables 2 and 3, all level of ID effects were statistically signiﬁcant. This indicates that ID-adolescentswith
IQ between 30 and 59 had higher mean scores on CSBQ subscales and total CSBQ score compared to ID-adolescents with IQ
between 60 and 80.
Table 1
Demographic characteristics of the sample.
Characteristics Years




Gender (N = 1035) N (%)
Boys 602 (58.2)
Girls 433 (41.8)
Level of IDa (N = 1038) N (%)
IQ 60–80 785 (75.6)
IQ 30–59 253 (24.4)
a As measured by school type.
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4. Discussion
ID-adolescents with somatic chronic diseases havemore PDD behavior than those without chronic diseases, in particular
milder forms of PDD behavior. This association is independent of having PDD/ADHD or not. Our ﬁndings suggest a
relationship between somatic chronic diseases in ID-adolescents and mild PDD behavior.
Differences are rather large, whereas effect sizes are mostly relative low. This can be explained by the fact that the
differences in mean scores on the CSBQ scales between the groups as well as the deviations of the means within each group
are considerably large, indicating considerably variation within each group.
4.1. Fit with other studies
To our knowledge, no previous studies have examined the association between somatic chronic diseases in ID-
adolescents and the full range of pervasive developmental disorder behavior (PDD behavior), includingmilder forms of PDD
behavior. However, our ﬁndings are mostly in line with two previous studies on ID-adolescents that used instruments
suitable for diagnosing severe forms of PDD behavior and reported prevalence rates of PDD based on diagnostic classiﬁcation
(Nordin & Gillberg, 1996; Steffenburg et al., 1996). Both studies used the Autism Behavior Checklist (ABC) and Childhood
Autism Rating Scale (CARS) and found higher prevalence rates of autistic spectrum disorder in ID-adolescent with epilepsy
(38%) (Steffenburg et al., 1996), cerebral palsy (11%) (Nordin & Gillberg, 1996) and severe visual impairment (50%) (Nordin &
Gillberg, 1996). Moreover, our ﬁndings are also mostly in line with studies on autism spectrum disorders and somatic
chronic diseases among adolescentswithout ID and among amixed group of adolescentswith andwithout ID (Ekstro¨m et al.,
2008; Freeman et al., 2005; Hendriksen & Vles, 2008; Kilincaslan & Mukaddes, 2009; Thome-Souza et al., 2004). These
studies showed that adolescents with somatic chronic diseases had a greater chance on autism spectrum disorders
compared to adolescents in the general population (Fombonne, 2009).
Our study thus shows that ﬁndings on severe cases of PDD can be extended to the full range of PDD behaviors.
4.2. Strength and limitations
The strength of this study is that it examined the association between somatic chronic diseases in adolescentswith ID and
PDD behavior in a large school-based sample representative for about 95% of the adolescents with ID. Another strength of
Table 2
Means and standard deviations on CSBQ scales and mean differences, adjusted for level of ID, and effect sizes between CSBQ scale scores in ID-adolescents
without chronic diseases and ID-adolescents with somatic chronic diseases (SCD).
Chronic diseases None SCD MDa p 95% CI Cohen’s db
CSBQ scales n M SD n M SD LL UL
Total score 392 15.27 12.89 233 21.95 14.66 6.53 <0.001 9.67 3.40 0.49
Not tuned behavior 389 4.34 4.33 232 5.48 4.80 1.09 0.043 2.17 0.02 0.25
Social withdrawn 392 2.76 3.56 233 4.29 4.23 1.51 <0.001 2.44 0.57 0.40
Orientation problems 383 2.65 2.81 232 4.18 3.40 1.51 <0.001 2.21 0.81 0.50
Not understanding 391 3.89 3.23 231 5.22 3.45 1.30 <0.001 2.02 0.57 0.40
Stereotyped behavior 389 0.88 1.71 231 1.59 2.19 0.68 0.006 1.22 0.13 0.37
Fear of changes 388 0.68 1.12 229 1.17 1.59 0.48 0.001 0.82 0.15 0.37
Note: CI, conﬁdence interval; LL, lower limit; MD, mean differences; SCD, somatic chronic diseases; UL, upper limit.
a All level of ID effects p< 0.001.
b Cohen thresholds: negligible effect (0.20); small effect (0.20 and <0.50); medium effect (0.50 and <0.80); large effect (0.80).
Table 3
Means and standard deviations on CSBQ scales and mean differences, adjusted for level of ID, and effect sizes between CSBQ scale scores in ID-adolescents
with only PDD/ADHD and ID-adolescents with somatic chronic diseases (SCD) in combination with PDD/ADHD.
Chronic diseases PDD/AHDH SCD + PDD/ADHD MDa p 95% CI Cohen’s db
CSBQ scales n M SD n M SD LL UL
Total score 163 33.82 16.60 144 41.03 16.62 7.21 <0.001 11.55 2.88 0.44
Not tuned behavior 163 9.92 5.71 144 10.38 5.46 0.46 1.000 1.95 1.02 0.08
Social withdrawn 163 6.50 5.16 144 8.59 5.35 2.08 <0.001 3.38 0.79 0.40
Orientation problems 163 5.73 3.47 144 7.32 3.72 1.59 <0.001 2.55 0.63 0.44
Not understanding 161 7.34 3.70 144 8.44 3.35 1.10 0.024 2.10 0.09 0.31
Stereotyped behavior 162 2.45 3.06 143 3.73 3.83 1.28 <0.001 2.02 0.53 0.37
Fear of changes 163 1.90 1.87 143 2.49 1.97 0.59 0.005 1.05 0.13 0.31
Note: CI, conﬁdence interval; LL, lower limit; MD, mean differences; SCD, somatic chronic diseases; UL, upper limit
a All level of ID effects p< 0.001.
b Cohen thresholds: negligible effect (0.20); small effect (0.20 and <0.50); medium effect (0.50 and <0.80); large effect (0.80).
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this study was the use of a speciﬁcally developed screening instrument that covers the full range of PDD behavior, including
milder forms. The CSBQ is useful for describing the severity and pattern of social deﬁcits in groups other than PDD. A
limitation is that the CBSQ is not intended for purposes of diagnostic classiﬁcation (Hartman et al., 2006). Another limitation
of the studywas the relatively low response rate (48%), but non-response analyses revealed that adolescents in the response
and non-response group did not differ on age, gender and educational level.
4.3. Implications for clinicians
Clinicians should be extra alert on PDD behavior, in particular the milder forms, in ID-adolescents when somatic chronic
diseases are present. Detecting PDD behavior in ID-adolescents and adequate treatment of those with mild PDD behavior is
important because these problems are very disabling for ID-adolescents in social and interpersonal situations and hinder
successful participation in the society (de Bildt et al., 2005a; Haccou &Hamond, 2006;Matson et al., 2008). The CSBQmay be
helpful as a ﬁrst screening device when there is a suspicion of PDD behavior, even when the problems are associated with
diagnoses outside autism spectrum disorders. In these cases, the score proﬁle of the adolescent may help to plan for more
speciﬁc diagnostic assessment and treatment, as well as their monitoring (Hartman et al., 2006).
4.4. Implications for research
Our study was the ﬁrst to assess the association between somatic chronic diseases in ID-adolescents and mild PDD
behavior. Therefore, they need conﬁrmational studies, which preferable use both the CSBQ and standardized diagnostic
instruments.
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